In this study, the levels of proliferation marker Ki-67 were examined in tumor tissues and showed significant inhibition in DET- and DETD-35-treated groups compared to the tumor control group (P < 0.05) (Supplementary Figure 1). This evidence concerns the gene MKI67 and neoplasm.